2022
DOI: 10.1016/j.omto.2022.02.002
|View full text |Cite
|
Sign up to set email alerts
|

Potential for reversing miR-634-mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 53 publications
1
5
0
Order By: Relevance
“…Further examination of the target gene and apoptotic marker expression showed downregulated levels of Asct2, Nrf2, and survivin, the corresponding human target genes of miR-634, as well as an increase in apoptotic cell numbers. These results suggested that miR-634 induced apoptosis in CMM cell lines through the same mechanisms that we reported in other human and murine malignant tumor cell lines, including HMM [17][18][19][20][21] This conclusion is crucial because it suggests the compatibility of the miR-634 treatment technique for CMM cases with HMM cases.…”
Section: Discussionsupporting
confidence: 74%
See 2 more Smart Citations
“…Further examination of the target gene and apoptotic marker expression showed downregulated levels of Asct2, Nrf2, and survivin, the corresponding human target genes of miR-634, as well as an increase in apoptotic cell numbers. These results suggested that miR-634 induced apoptosis in CMM cell lines through the same mechanisms that we reported in other human and murine malignant tumor cell lines, including HMM [17][18][19][20][21] This conclusion is crucial because it suggests the compatibility of the miR-634 treatment technique for CMM cases with HMM cases.…”
Section: Discussionsupporting
confidence: 74%
“…We previously demonstrated that the introduction of synthetic double-strand (ds)-miR-634 mimic triggered apoptotic cell death by directly targeting genes associated with cytoprotective processes, including glutaminolysis (ASCT2), autophagy (LAMP2), antioxidant activity (NRF2), anti-apoptotic activity (cIAP1, survivin, APIP, and XIAP), and mitochondrial function (OPA1 and TFAM) in various human cancer cell lines, including those of HMM [17][18][19][20][21]. Delivery of a synthetic ds-miR-634 mimic into tumor cells using lipid nanoparticles (LNPs) as the drug delivery system was therapeutically effective in a xenograft mouse model of pancreatic cancer [19].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Apaf-1 interacting protein (APIP) functions as an endogenous inhibitor of apoptotic cell death by inhibiting caspase activity. Its upregulation leads to chemotherapeutic resistance in cancer cells [ 75 ]. In our work, we did not find changes in APIP level in HNSCC patients, but it can be assumed that evaluation of the expression level of this gene will be of interest to researchers when studying the mechanisms of tumor therapeutic resistance.…”
Section: Discussionmentioning
confidence: 99%
“…10,11 Research on nucleic acid therapeutics using miRNAs against cancer are no more at a level of infancy; such therapeutics are undergoing phase I and II testing in humans. [12][13][14][15] Some organ-specific miRNAs regulate PKM isoform expression by directly targeting PTBP1, which is the splicer responsible for PKM2-dominant expression. 16 The miRNAs targeting PTBP1 are extensively studied because of their role in regulating cancer-specific energy metabolism (ie, the Warburg effect).…”
Section: Introductionmentioning
confidence: 99%